Clinical Trial Update: De Novo Lipogenesis in Severity of NAFLD

View source ↗

Summary

A completed clinical trial from the University of Missouri-Columbia investigates the role of de novo lipogenesis in the severity of nonalcoholic fatty liver dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Status: COMPLETED